HDAC2 and 3 are recruited by Kruppel-like factor 4 (KLF-4) at the vascular endothelial growth factor (VEGF) promoter to participate in transcriptional repression of VEGF, which has been first reported in breast cancer [47]. Here, KLF4 is linked to breast carcinoma.